Back to Journals » Biologics: Targets and Therapy » Volume 12

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection

Total article views   Abstract views HTML views PDF downloads Totals
15,338 Dovepress* 6,523 1,202+ 1,499 7,725
PubMed Central* 0 7,613 800 7,613
Totals 6,523 8,815 2,299 15,338
*Since 18 January 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 3 4

View citations on PubMed Central and Google Scholar